A Prospective, 5-year Registry Study to Monitor

Project: Research project

Project Details

Description

A Prospective, 5-year Registry Study to Monitor the Susceptibility to Aztreonam of Pseudomonas aeruginosa (PA) Isolates from Patients with Cystic Fibrosis in the United States
StatusFinished
Effective start/end date7/1/117/1/17

Funding

  • Gilead Sciences, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.